| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 2,601.4 | 2,179.4 | 2,011.9 | 1,423.1 |
yoy growth (%) | 19.36 | 8.32 | 41.37 | 18.5 |
Raw materials | -749 | -526.5 | -519.4 | -381.7 |
As % of sales | 28.79 | 24.15 | 25.81 | 26.82 |
Employee costs | -697.8 | -641.5 | -572.2 | -376.9 |
As % of sales | 26.82 | 29.43 | 28.44 | 26.48 |
Other costs | -361.2 | -341.4 | -303.6 | -274 |
As % of sales (Other Cost) | 13.88 | 15.66 | 15.09 | 19.25 |
Operating profit | 793.4 | 670 | 616.7 | 390.5 |
OPM | 30.49 | 30.74 | 30.65 | 27.44 |
Depreciation | -309.7 | -274.5 | -219.3 | -131.4 |
Interest expense | -24.1 | -27.7 | -34.6 | -22.7 |
Other income | 52.8 | 64.6 | 81.6 | 135.7 |
Profit before tax | 512.4 | 432.4 | 444.4 | 372.1 |
Taxes | -87.9 | -63.7 | -104.2 | -67 |
Tax rate | -17.15 | -14.73 | -23.44 | -18 |
Minorities and other | 0 | 0 | 0 | 0 |
Adj. profit | 424.5 | 368.7 | 340.2 | 305.1 |
Exceptional items | -30.7 | 35 | 71.3 | 0 |
Net profit | 393.8 | 403.7 | 411.5 | 305.1 |
yoy growth (%) | -2.45 | -1.89 | 34.87 | 6.19 |
NPM | 15.13 | 18.52 | 20.45 | 21.43 |
The purchase is anticipated to enhance Syngene's position in the biologics contract development and manufacturing organization (CDMO) arena, specifically in the US market.
The company reported an operating EBITDA of ₹343.60 Crore in the quarter four of FY25. It registered a growth of 8.4% on a year-on-year basis.
This acquisition will also augment Syngene’s biologics capabilities and further strengthen its global presence.
The company's revenue from operations also grew healthily, up by 10.6% YoY to ₹943 crore, as against ₹853.5 crore in Q3 FY24.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
